HOME >> BIOLOGY >> NEWS
New York microbiologists awarded research grants in antibiotic resistance and lyme disease

VALHALLA, N.Y., April 15, 2004--Two microbiologists at New York Medical College will further their research in antibiotics and Lyme disease with prestigious awards from the Guggenheim Memorial Foundation and the Centers for Disease Control and Prevention (CDC). They are Felipe C. Cabello, M.D., of Hartsdale, N.Y., and Ira S. Schwartz, Ph.D., of Spring Valley, N.Y.

Dr. Cabello, professor of microbiology and immunology, is a Guggenheim Fellow 2004 for the "Public Health Implications of Antibiotic Use in Aquaculture." He will explore the emergence of bacterial antibiotic resistance that occurs between aquatic and terrestrial environments in the salmon aquaculture industry in Chile. The first faculty member to win a Guggenheim fellowship, which is given "on the basis of distinguished past achievement and exceptional promise for future accomplishment," Dr. Cabello joined the College in 1978. He was born in Santiago, Chile, and graduated from the University of Chile School of Medicine. Dr. Cabello did postdoctoral fellowships at Stanford University and the University of Chicago.

Ira S. Schwartz, Ph.D., professor and chairman of the Department of Microbiology and Immunology, is the principal investigator of the CDC award to New York Medical College, one of ten institutions sharing more than $3.5 million for new research on Lyme disease. The studies are designed to improve understanding of the disease and to examine new methods for testing, prevention and control. His award is for "Lyme Disease Diagnosis with Host Gene Expression Arrays."

Dr. Schwartz will examine how cells from mice and humans respond to infection by Lyme bacteria--using a technique called microarray analysis to monitor how gene expression changes with infection--and possibly to develop new diagnostic tests for active infection based on these changes. He joined the College in 1980, spending 22 years in the Department of Biochemistry and Molecular Biology before being named chairman
'"/>

Contact: Donna E. Moriarty
donna_moriarty@nymc.edu
914-594-4536
New York Medical College
16-Apr-2004


Page: 1 2

Related biology news :

1. U of T microbiologists achieve results with pattern recognition software
2. Colorado State microbiologists help identify cell membrane substance that could boost vaccines for tuberculosis, other diseases
3. Ecology of infectious diseases grants awarded
4. Joslin President awarded medal from international diabetes organization
5. UNC researchers awarded $8.65 million from National Institute on Aging
6. ESA awarded new SEEDS grant
7. $5.5 million awarded to tree-ring research and climate studies
8. Dartmouth Medical School awarded $9 million grant for genomics research
9. BioTime awarded NIH grant to aid Hetacool development
10. Researchers awarded $2 million to create high-tech tools for fighting wildfires
11. USC awarded $3.5 million to study DNA enzyme

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... , ... July 17, 2020 , ... Commercial launch readiness ... pharma’s ability to discover a COVID cure or vaccine, the global economic downturn will ... price pressure is not going away and capturing full value from every product launch ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... B.V. (MBS) has announced a publication detailing the use of its revolutionary ... polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... software and software-driven clinical data services that accelerate drug development, is collaborating with ... an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the first ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license ... to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering stem ... 200 million stem cells. Depending on the patient's condition, treatment may be offered IV, ... die having some form of Alzheimers dementia, and the incidence continues to increase as ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... competitively procured purchasing contracts to its membership, recently named BioFit Engineered Products ... with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts ...
Breaking Biology Technology:
Cached News: